S. Sawadogo

Ankylosing spondylitis in three Sub-Saharan populations: HLA-B*27 and HLA-B*14 contribution.

C. López-Larrea, A. López-Vázquez, R. Díaz-Peña, 2012, Tissue antigens.

How NETosis could drive “Post-COVID-19 syndrome” among survivors

L. Hensley, Bonnie Dighero-kemp, D. Ouédraogo, 2020, Immunology Letters.

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study

H. Tinto, I. Valéa, T. Rouamba, 2021, Therapeutics and clinical risk management.

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

S. Lees, D. Watson-Jones, M. Belson, 2020, Trials.

Rheumatoid arthritis in Burkina Faso: clinical and serological profiles

H. Tiéno, D. Ouédraogo, Y. Drabo, 2011, Clinical Rheumatology.

[Prevalence and clinical profile of hemophilia of black Africans in urban areas of the Ivory Coast].

I. Sanogo, S. Sawadogo, A. Ségbéna, 1990, Medecine tropicale : revue du Corps de sante colonial.